250MG Medicinal Erythromycin Tablets Antibiotic 10*10& acute;s / Box , Protect From Light - AIA-1
250MG Medicinal Erythromycin Tablets Antibiotic 10*10& acute;s / Box , Protect From Light For Sale, Most Competitive Price, Fast Delivery, Custom Service, Wholesale 250MG Medicinal Erythromycin Tablets Antibiotic 10*10& acute;s / Box , Protect From Light, Made in China, High Quality Products!, China cheap prodocuts, china suppliers Supplier, Manufacturer.Erythromycin Tablets 250MG ?Antibiotic 10*10& acute;s / Box ? 1000‘s / Bottle
?
Erythromycin?tablets 250MG
?
COMPOSITION:
Each?tablet?contains?250 mg Erythromycin base.
?
PHARMACOLOGICAL?ACTION:
Erythromycin?is an antibiotic belonging to the macrolide group and acts by inhibition of protein synthesis of the micro organisms.
It produces peak plasma levels in one to four hours, depending on the rapidity of gastric emptying. The level declines after four to six hours.
The antibiotic is concentrated in the liver and excreted in active form in the bile. About 2 - 5% of the drug is excreted in the urine, also in the active form.
?
INDICATIONS:
Infections due to susceptible micro-organisms such as gram positive cocci and bacilli. When possible, cultures and sensitivity tests should be done.
Erythromycin stearate has been found to be effective in vitro against Gram-positive organisms such as Staphylococcus aureus*, Streptococcus pyogenes and Streptococcus viridans *, enterococci and pneumococci. It also inhibits some strains of Neisseriae, Haemophilus influenzae, Corynebacterium diphtheriae, Listeria, Pasteurella and Treponema.
Erythromycin stearate is an alternate treatment for Neisseria gonorrhoea and primary syphilis (T. pallidum) in patients allergic to the penicillins. Before treatment of gonorrhoea patients who are suspected of also having syphilis should have a microscopic examination for T. pallidum.
?
CONTRA-INDICATIONS:
Patients with impaired liver function or patients who have developed jaundice or other symptoms of liver toxicity during previous treatment with an erythromycin. Known hypersensitivity to erythromycin.
?
WARNING:
The safety of erythromycin for use during pregnancy and lactation has not been established.
?
DOSAGE?AND?DIRECTIONS?FOR?USE:
In order to obtain optimal blood levels, Rubimycin should be given on an empty stomach.
For adults:
250 to 500 mg every 6 hours depending on the severity of the infection.
For children:
The basic recommendation ranges from 30 to 50 mg/kg/day or more, depending on the severity of the infections: these amounts are administered in four divided doses.
?
SIDE?EFFECTS?AND?SPECIAL?PRECAUTIONS:
Caution should be taken in administering erythromycin stearate to patients with impaired hepatic function.
Gastro-intestinal disturbances e.g. nausea, vomiting, abdominal cramps and diarrhoea may occur. Sensitisation to erythromycin and hypersensitivity reactions such as fever, eosinophilia and skin reactions may occur. Anaphylaxis has been reported.
Super-infection caused by resistant organisms.
Pseudo-membranous colitis may occur.
Reversible deafness has occurred after high doses of erythromycin.
Hepatotoxicity has been reported after administration of erythromycin, but most commonly as the estolate.
Erythromycin should not be given concomitantly with chloramphenicol or thiamphenicol. Erythromycin may potentiate the action of carbamazepine, cyclosporin, corticosteroids, digoxin, theophylline and warfarin, probably by inhibition of their hepatic metabolism.
STORAGE?INSTRUCTIONS:
Keep container tightly closed and store below 25°C. Protect from light.
KEEP OUT OF REACH OF CHILDREN.
ZHEJIANG MEDICINES&HEALTH PRODUCTS I/E CO.,LTD
Address: 101-2, N. Zhongshan Road, Hangzhou, Zhejiang, China (Mainland), Hangzhou, Zhejiang, China, 310000
Tel: 86-571-28935880
Zhejiang Medicines and Health Products Import &Export Co., Ltd (ZMC) is a subsidiary of Zhejiang International Business Group Co., Ltd. ZMC has evolved from a former state-owned enterprise in 1999 into a shareholding company with modern corporate governance structure and has been listed ever since 1990 among the top 500 exporters of China for 16 consecutive years.
Through incessant efforts over the years on the exploitation for new and high quality products that help better meet our customers鈥?needs and strengthen the competitiveness, our export revenue in 2014 hit a record high of USD 589 millions,and listed among the top 5 export of pharmacetical formulations in China,2013 and 2014.
We have established extensive and pleasant working ties with numerous manufacturers within China on a long-term basis and enjoyed a reliable marketing network in over 100 countries and regions in Asia, Europe, America, Africa and Oceania.
In recent years, according to the needs of our business development, extension of supply chain and strategic objectives, ZMC has invested in over 10 related manufactures in the form of share holding or share purchasing, thus boosting the marketing abroad for the related export products